 | • レポートコード：MRC2-11QY12450 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はIVD感染症のグローバル市場について調査・分析したレポートです。種類別（生化学的診断、免疫診断、分子診断、微生物学的診断、尿診断、凝固診断、その他）市場規模、用途別（個人、商業、学術、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別IVD感染症の競争状況、市場シェア ・世界のIVD感染症市場：種類別市場規模 2015年-2020年（生化学的診断、免疫診断、分子診断、微生物学的診断、尿診断、凝固診断、その他） ・世界のIVD感染症市場：種類別市場規模予測 2021年-2026年（生化学的診断、免疫診断、分子診断、微生物学的診断、尿診断、凝固診断、その他） ・世界のIVD感染症市場：用途別市場規模 2015年-2020年（個人、商業、学術、その他） ・世界のIVD感染症市場：用途別市場規模予測 2021年-2026年（個人、商業、学術、その他） ・北米のIVD感染症市場分析：米国、カナダ ・ヨーロッパのIVD感染症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのIVD感染症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のIVD感染症市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのIVD感染症市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche Diagnostics、Abbott Laboratories、Abbott、Gen-Probe、Becton Dickinson (BD)、Bio-Rad Laboratories、Siemens Healthcare、Biomérieux、Danaher、Thermo Fisher、Sysmex ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.).
Geographically, North America is the world’s largest extracorporeal diagnostic market. Europe and the United States together account for more than 65 percent of the global market. Japan has the largest share of the Asian in vitro diagnosis market, with an 8.73% market share.
Market Analysis and Insights: Global IVD Infectious Disease Market
The global IVD Infectious Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global IVD Infectious Disease Scope and Market Size
IVD Infectious Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global IVD Infectious Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche Diagnostics
Abbott Laboratories
Abbott
Gen-Probe
Becton Dickinson (BD)
Bio-Rad Laboratories
Siemens Healthcare
Biomérieux
Danaher
Thermo Fisher
Sysmex
Market segment by Type, the product can be split into
Biochemical Diagnosis
Immune Diagnosis
Molecular Diagnosis
Microbiological Diagnosis
Urine Diagnosis
Coagulation Diagnosis
Other
Market segment by Application, split into
Personal
Commercial
Academic
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by IVD Infectious Disease Revenue
1.4 Market by Type
1.4.1 Global IVD Infectious Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biochemical Diagnosis
1.4.3 Immune Diagnosis
1.4.4 Molecular Diagnosis
1.4.5 Microbiological Diagnosis
1.4.6 Urine Diagnosis
1.4.7 Coagulation Diagnosis
1.4.8 Other
1.5 Market by Application
1.5.1 Global IVD Infectious Disease Market Share by Application: 2020 VS 2026
1.5.2 Personal
1.5.3 Commercial
1.5.4 Academic
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global IVD Infectious Disease Market Perspective (2015-2026)
2.2 Global IVD Infectious Disease Growth Trends by Regions
2.2.1 IVD Infectious Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 IVD Infectious Disease Historic Market Share by Regions (2015-2020)
2.2.3 IVD Infectious Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 IVD Infectious Disease Market Growth Strategy
2.3.6 Primary Interviews with Key IVD Infectious Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top IVD Infectious Disease Players by Market Size
3.1.1 Global Top IVD Infectious Disease Players by Revenue (2015-2020)
3.1.2 Global IVD Infectious Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global IVD Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global IVD Infectious Disease Market Concentration Ratio
3.2.1 Global IVD Infectious Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by IVD Infectious Disease Revenue in 2019
3.3 IVD Infectious Disease Key Players Head office and Area Served
3.4 Key Players IVD Infectious Disease Product Solution and Service
3.5 Date of Enter into IVD Infectious Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global IVD Infectious Disease Historic Market Size by Type (2015-2020)
4.2 Global IVD Infectious Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global IVD Infectious Disease Market Size by Application (2015-2020)
5.2 Global IVD Infectious Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America IVD Infectious Disease Market Size (2015-2020)
6.2 IVD Infectious Disease Key Players in North America (2019-2020)
6.3 North America IVD Infectious Disease Market Size by Type (2015-2020)
6.4 North America IVD Infectious Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe IVD Infectious Disease Market Size (2015-2020)
7.2 IVD Infectious Disease Key Players in Europe (2019-2020)
7.3 Europe IVD Infectious Disease Market Size by Type (2015-2020)
7.4 Europe IVD Infectious Disease Market Size by Application (2015-2020)
8 China
8.1 China IVD Infectious Disease Market Size (2015-2020)
8.2 IVD Infectious Disease Key Players in China (2019-2020)
8.3 China IVD Infectious Disease Market Size by Type (2015-2020)
8.4 China IVD Infectious Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan IVD Infectious Disease Market Size (2015-2020)
9.2 IVD Infectious Disease Key Players in Japan (2019-2020)
9.3 Japan IVD Infectious Disease Market Size by Type (2015-2020)
9.4 Japan IVD Infectious Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia IVD Infectious Disease Market Size (2015-2020)
10.2 IVD Infectious Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia IVD Infectious Disease Market Size by Type (2015-2020)
10.4 Southeast Asia IVD Infectious Disease Market Size by Application (2015-2020)
11 India
11.1 India IVD Infectious Disease Market Size (2015-2020)
11.2 IVD Infectious Disease Key Players in India (2019-2020)
11.3 India IVD Infectious Disease Market Size by Type (2015-2020)
11.4 India IVD Infectious Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America IVD Infectious Disease Market Size (2015-2020)
12.2 IVD Infectious Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America IVD Infectious Disease Market Size by Type (2015-2020)
12.4 Central & South America IVD Infectious Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Details
13.1.2 Roche Diagnostics Business Overview
13.1.3 Roche Diagnostics IVD Infectious Disease Introduction
13.1.4 Roche Diagnostics Revenue in IVD Infectious Disease Business (2015-2020))
13.1.5 Roche Diagnostics Recent Development
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Details
13.2.2 Abbott Laboratories Business Overview
13.2.3 Abbott Laboratories IVD Infectious Disease Introduction
13.2.4 Abbott Laboratories Revenue in IVD Infectious Disease Business (2015-2020)
13.2.5 Abbott Laboratories Recent Development
13.3 Abbott
13.3.1 Abbott Company Details
13.3.2 Abbott Business Overview
13.3.3 Abbott IVD Infectious Disease Introduction
13.3.4 Abbott Revenue in IVD Infectious Disease Business (2015-2020)
13.3.5 Abbott Recent Development
13.4 Gen-Probe
13.4.1 Gen-Probe Company Details
13.4.2 Gen-Probe Business Overview
13.4.3 Gen-Probe IVD Infectious Disease Introduction
13.4.4 Gen-Probe Revenue in IVD Infectious Disease Business (2015-2020)
13.4.5 Gen-Probe Recent Development
13.5 Becton Dickinson (BD)
13.5.1 Becton Dickinson (BD) Company Details
13.5.2 Becton Dickinson (BD) Business Overview
13.5.3 Becton Dickinson (BD) IVD Infectious Disease Introduction
13.5.4 Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2015-2020)
13.5.5 Becton Dickinson (BD) Recent Development
13.6 Bio-Rad Laboratories
13.6.1 Bio-Rad Laboratories Company Details
13.6.2 Bio-Rad Laboratories Business Overview
13.6.3 Bio-Rad Laboratories IVD Infectious Disease Introduction
13.6.4 Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2015-2020)
13.6.5 Bio-Rad Laboratories Recent Development
13.7 Siemens Healthcare
13.7.1 Siemens Healthcare Company Details
13.7.2 Siemens Healthcare Business Overview
13.7.3 Siemens Healthcare IVD Infectious Disease Introduction
13.7.4 Siemens Healthcare Revenue in IVD Infectious Disease Business (2015-2020)
13.7.5 Siemens Healthcare Recent Development
13.8 Biomérieux
13.8.1 Biomérieux Company Details
13.8.2 Biomérieux Business Overview
13.8.3 Biomérieux IVD Infectious Disease Introduction
13.8.4 Biomérieux Revenue in IVD Infectious Disease Business (2015-2020)
13.8.5 Biomérieux Recent Development
13.9 Danaher
13.9.1 Danaher Company Details
13.9.2 Danaher Business Overview
13.9.3 Danaher IVD Infectious Disease Introduction
13.9.4 Danaher Revenue in IVD Infectious Disease Business (2015-2020)
13.9.5 Danaher Recent Development
13.10 Thermo Fisher
13.10.1 Thermo Fisher Company Details
13.10.2 Thermo Fisher Business Overview
13.10.3 Thermo Fisher IVD Infectious Disease Introduction
13.10.4 Thermo Fisher Revenue in IVD Infectious Disease Business (2015-2020)
13.10.5 Thermo Fisher Recent Development
13.11 Sysmex
10.11.1 Sysmex Company Details
10.11.2 Sysmex Business Overview
10.11.3 Sysmex IVD Infectious Disease Introduction
10.11.4 Sysmex Revenue in IVD Infectious Disease Business (2015-2020)
10.11.5 Sysmex Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. IVD Infectious Disease Key Market Segments
Table 2. Key Players Covered: Ranking by IVD Infectious Disease Revenue
Table 3. Ranking of Global Top IVD Infectious Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global IVD Infectious Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biochemical Diagnosis
Table 6. Key Players of Immune Diagnosis
Table 7. Key Players of Molecular Diagnosis
Table 8. Key Players of Microbiological Diagnosis
Table 9. Key Players of Urine Diagnosis
Table 10. Key Players of Coagulation Diagnosis
Table 11. Key Players of Other
Table 12. Global IVD Infectious Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global IVD Infectious Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global IVD Infectious Disease Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global IVD Infectious Disease Market Share by Regions (2015-2020)
Table 16. Global IVD Infectious Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global IVD Infectious Disease Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. IVD Infectious Disease Market Growth Strategy
Table 22. Main Points Interviewed from Key IVD Infectious Disease Players
Table 23. Global IVD Infectious Disease Revenue by Players (2015-2020) (Million US$)
Table 24. Global IVD Infectious Disease Market Share by Players (2015-2020)
Table 25. Global Top IVD Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Infectious Disease as of 2019)
Table 26. Global IVD Infectious Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players IVD Infectious Disease Product Solution and Service
Table 29. Date of Enter into IVD Infectious Disease Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global IVD Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 32. Global IVD Infectious Disease Market Size Share by Type (2015-2020)
Table 33. Global IVD Infectious Disease Revenue Market Share by Type (2021-2026)
Table 34. Global IVD Infectious Disease Market Size Share by Application (2015-2020)
Table 35. Global IVD Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 36. Global IVD Infectious Disease Market Size Share by Application (2021-2026)
Table 37. North America Key Players IVD Infectious Disease Revenue (2019-2020) (Million US$)
Table 38. North America Key Players IVD Infectious Disease Market Share (2019-2020)
Table 39. North America IVD Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 40. North America IVD Infectious Disease Market Share by Type (2015-2020)
Table 41. North America IVD Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 42. North America IVD Infectious Disease Market Share by Application (2015-2020)
Table 43. Europe Key Players IVD Infectious Disease Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players IVD Infectious Disease Market Share (2019-2020)
Table 45. Europe IVD Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 46. Europe IVD Infectious Disease Market Share by Type (2015-2020)
Table 47. Europe IVD Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 48. Europe IVD Infectious Disease Market Share by Application (2015-2020)
Table 49. China Key Players IVD Infectious Disease Revenue (2019-2020) (Million US$)
Table 50. China Key Players IVD Infectious Disease Market Share (2019-2020)
Table 51. China IVD Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 52. China IVD Infectious Disease Market Share by Type (2015-2020)
Table 53. China IVD Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 54. China IVD Infectious Disease Market Share by Application (2015-2020)
Table 55. Japan Key Players IVD Infectious Disease Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players IVD Infectious Disease Market Share (2019-2020)
Table 57. Japan IVD Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 58. Japan IVD Infectious Disease Market Share by Type (2015-2020)
Table 59. Japan IVD Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 60. Japan IVD Infectious Disease Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players IVD Infectious Disease Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players IVD Infectious Disease Market Share (2019-2020)
Table 63. Southeast Asia IVD Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia IVD Infectious Disease Market Share by Type (2015-2020)
Table 65. Southeast Asia IVD Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia IVD Infectious Disease Market Share by Application (2015-2020)
Table 67. India Key Players IVD Infectious Disease Revenue (2019-2020) (Million US$)
Table 68. India Key Players IVD Infectious Disease Market Share (2019-2020)
Table 69. India IVD Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 70. India IVD Infectious Disease Market Share by Type (2015-2020)
Table 71. India IVD Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 72. India IVD Infectious Disease Market Share by Application (2015-2020)
Table 73. Central & South America Key Players IVD Infectious Disease Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players IVD Infectious Disease Market Share (2019-2020)
Table 75. Central & South America IVD Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America IVD Infectious Disease Market Share by Type (2015-2020)
Table 77. Central & South America IVD Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America IVD Infectious Disease Market Share by Application (2015-2020)
Table 79. Roche Diagnostics Company Details
Table 80. Roche Diagnostics Business Overview
Table 81. Roche Diagnostics Product
Table 82. Roche Diagnostics Revenue in IVD Infectious Disease Business (2015-2020) (Million US$)
Table 83. Roche Diagnostics Recent Development
Table 84. Abbott Laboratories Company Details
Table 85. Abbott Laboratories Business Overview
Table 86. Abbott Laboratories Product
Table 87. Abbott Laboratories Revenue in IVD Infectious Disease Business (2015-2020) (Million US$)
Table 88. Abbott Laboratories Recent Development
Table 89. Abbott Company Details
Table 90. Abbott Business Overview
Table 91. Abbott Product
Table 92. Abbott Revenue in IVD Infectious Disease Business (2015-2020) (Million US$)
Table 93. Abbott Recent Development
Table 94. Gen-Probe Company Details
Table 95. Gen-Probe Business Overview
Table 96. Gen-Probe Product
Table 97. Gen-Probe Revenue in IVD Infectious Disease Business (2015-2020) (Million US$)
Table 98. Gen-Probe Recent Development
Table 99. Becton Dickinson (BD) Company Details
Table 100. Becton Dickinson (BD) Business Overview
Table 101. Becton Dickinson (BD) Product
Table 102. Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2015-2020) (Million US$)
Table 103. Becton Dickinson (BD) Recent Development
Table 104. Bio-Rad Laboratories Company Details
Table 105. Bio-Rad Laboratories Business Overview
Table 106. Bio-Rad Laboratories Product
Table 107. Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2015-2020) (Million US$)
Table 108. Bio-Rad Laboratories Recent Development
Table 109. Siemens Healthcare Company Details
Table 110. Siemens Healthcare Business Overview
Table 111. Siemens Healthcare Product
Table 112. Siemens Healthcare Revenue in IVD Infectious Disease Business (2015-2020) (Million US$)
Table 113. Siemens Healthcare Recent Development
Table 114. Biomérieux Business Overview
Table 115. Biomérieux Product
Table 116. Biomérieux Company Details
Table 117. Biomérieux Revenue in IVD Infectious Disease Business (2015-2020) (Million US$)
Table 118. Biomérieux Recent Development
Table 119. Danaher Company Details
Table 120. Danaher Business Overview
Table 121. Danaher Product
Table 122. Danaher Revenue in IVD Infectious Disease Business (2015-2020) (Million US$)
Table 123. Danaher Recent Development
Table 124. Thermo Fisher Company Details
Table 125. Thermo Fisher Business Overview
Table 126. Thermo Fisher Product
Table 127. Thermo Fisher Revenue in IVD Infectious Disease Business (2015-2020) (Million US$)
Table 128. Thermo Fisher Recent Development
Table 129. Sysmex Company Details
Table 130. Sysmex Business Overview
Table 131. Sysmex Product
Table 132. Sysmex Revenue in IVD Infectious Disease Business (2015-2020) (Million US$)
Table 133. Sysmex Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IVD Infectious Disease Market Share by Type: 2020 VS 2026
Figure 2. Biochemical Diagnosis Features
Figure 3. Immune Diagnosis Features
Figure 4. Molecular Diagnosis Features
Figure 5. Microbiological Diagnosis Features
Figure 6. Urine Diagnosis Features
Figure 7. Coagulation Diagnosis Features
Figure 8. Other Features
Figure 9. Global IVD Infectious Disease Market Share by Application: 2020 VS 2026
Figure 10. Personal Case Studies
Figure 11. Commercial Case Studies
Figure 12. Academic Case Studies
Figure 13. Other Case Studies
Figure 14. IVD Infectious Disease Report Years Considered
Figure 15. Global IVD Infectious Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global IVD Infectious Disease Market Share by Regions: 2020 VS 2026
Figure 17. Global IVD Infectious Disease Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global IVD Infectious Disease Market Share by Players in 2019
Figure 20. Global Top IVD Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Infectious Disease as of 2019
Figure 21. The Top 10 and 5 Players Market Share by IVD Infectious Disease Revenue in 2019
Figure 22. North America IVD Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe IVD Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China IVD Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan IVD Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia IVD Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India IVD Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America IVD Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed
性感染症（STD）診断の世界市場（～2026年） Sexually transmitted diseases (STDs) are infections that are passed from one person to another through sexual contact. The causes of STDs are bacteria, parasites, yeast, and viruses. Sexually Transmitted Disease is growing at a faster pace owing to the rising incidences of unprotected sex, lack of a…- ミトコンドリアミオパチー診断・治療の世界市場（～2026年） Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate "ragged red" muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an incr…
- 肝炎検査診断の世界市場（～2026年） Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic condition. Hepatitis testing refer…
- 髄膜炎診断・治療の世界市場（～2026年） Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. The most common symptoms are fever, headache, and neck stiffness. Other symptoms include confusion or altered consciousness, vomiting, and an inability to tolerate …
- 胸膜炎診断の世界市場（～2026年） Pleurisy is the inflammation of the membrane known as pleura that surrounds the lungs inside the chest cavity. People suffering with pleurisy can experience chest pain while breathing. This disease is characterized by symptoms such as shortness of breath, cough, fever, and weight loss. Market Analys…